1Unger Unger J, Fredfickson L. A primer or intensive diabetes management and insulin pump therapy [J]. Primary Care Rep 1997;3:9- 18.
2Bruce B, Richard W, David B, et al. Comparison of insulin aspart with buffered regular insulin and insulin lispro in contions subctancous insulin infusion. Diabetes care 2002;25:439-333.
3Linkeschova R, Raoul M, Bott U, et al. Less severe hypoglycemia, better metabolic control, and improve quality of life in Type 1 diabetes Mellitus with continuous subcutaneous insulin infusion(CS Ⅱ)therapy, an observational study of 100 consecutive patients followed for a mean of 2 years. Diabetes Med 2002; 17(9) :746 - 756.
4Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokineties and pharmacodynamics of subcutaneous injection of long acting human insuli analog glargine, NPH insulin, and Ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000 ; 49 : 2142-2148.
